Company / Cash per Share
Oric Pharmaceuticals, Inc. Cash per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.52
FY2025
5-year range
$0.45 / $5.95
FY2021-FY2025
Trend
-38.9%
vs FY2024
Sector context
#168 of 205
Health Care
What the data says
Oric Pharmaceuticals, Inc.'s cash per share of $0.52 is lower than 82% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 7 years, ranging from $0.45 in FY2023 to $46.94 in FY2019.
Based on SEC 10-K filings.
0.52 in FY2025 with a 5-year CAGR of -32.0%.
Improved from $0.45 to $0.52 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -32.4%
- 5-Year CAGR
- -32.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 205This company $0.52 Sector average $72.93
▼
-99.3% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 38.9% year-over-year.
- Ranks #168 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.52 | -38.9% |
| FY2024 | $0.85 | +87.5% |
| FY2023 | $0.45 | -73.0% |
| FY2022 | $1.69 | -71.7% |
| FY2021 | $5.95 | +66.6% |
| FY2020 | $3.58 | -92.4% |
| FY2019 | $46.94 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026